chinese glp-1 Companies Are Developing Advanced Drugs Vincentage to chase Lilly to

Tirzepatide is a promising drug withdual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor activation that has revolutionized the treatment of type 2 diabetesmellitus (T2DM) as an adjunct to ...

Years after approving three glucagon-like peptide-1 (GLP-1) receptor agonists to treat obesity, the U.S

Amylyx continues to expect topline data in Q3 2026, and if approved, a commercial launch in 2027

Explore meals that boost adherence, satiety, and results.

Ledisa GLP-1 patches offer a simple and modern approach to wellness

Indias drug regulator has issued a strict advisory prohibiting direct and indirect promotion of prescription weight-loss drugs, including digital campaigns, influencer endorsements and disease-awareness initiatives that could act as surrogate advertising